ERNA Eterna Therapeutics Inc

CAMBRIDGE, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) ( Eterna or the Company ), a life science company committed to realizing the potential of mRNA cell...

Eterna Therapeutics Inc. (NASDAQ:ERNA Get Free Report) saw a large increase in short interest in January. As of January 31st, there was short interest totalling 147,900 shares, an increase of...

Eterna Therapeutics files to sell 18.2M shares for holders...

CAMBRIDGE, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) ( Eterna or the Company ), a life science company committed to realizing the potential of mRNA cell...